Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Curr Opin Allergy Clin Immunol. 2010 Oct;10(5):493–497. doi: 10.1097/ACI.0b013e32833dfa11

Table 1.

Conditions that promote immune privilege of corneal allografts

Condition Mode of action Effect on immune privilege
Absence of lymph vessels Prevents APC migration to regional lymph nodes Prevents induction of immune responses
FasL Induces apoptosis of activated T cells at the graft–host interface Blocks expression of immune responses
PD-L1 Inhibits T cell proliferation and induces T cell apoptosis at the graft–host interface Blocks expression of immune responses
ACAID Suppresses DTH responses and deviates alloantibody responses to noncomplement-fixing isotypes Prevents both induction and expression of immune responses
Tregs Suppress immune responses Prevent both induction and expression of immune responses

ACAID, anterior chamber-associated immune deviation; DTH, delayed-type hypersensitivity; FasL, Fas ligand (CD95L); PD-L1, programmed death ligand 1; Tregs, T regulatory cells.